Lindbrook Capital’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $26.2K | Buy |
229
+33
| +17% | +$3.77K | ﹤0.01% | 1244 |
|
|
2024
Q4 | $9.88K | Hold |
196
| – | – | ﹤0.01% | 1658 |
|
|
2024
Q3 | $9.07K | Hold |
196
| – | – | ﹤0.01% | 1722 |
|
|
2024
Q2 | $6.37K | Buy |
196
+80
| +69% | +$2.6K | ﹤0.01% | 1878 |
|
|
2024
Q1 | $2.92K | Buy |
116
+2
| +2% | +$50 | ﹤0.01% | 2111 |
|
|
2023
Q4 | $3.7K | Hold |
114
| – | – | ﹤0.01% | 2037 |
|
|
2023
Q3 | $3.11K | Buy |
114
+18
| +19% | +$490 | ﹤0.01% | 1968 |
|
|
2023
Q2 | $2.14K | Sell |
96
-84
| -47% | -$1.87K | ﹤0.01% | 2126 |
|
|
2023
Q1 | $3.9K | Buy |
180
+84
| +88% | +$1.82K | ﹤0.01% | 1959 |
|
|
2022
Q4 | $1.95K | Sell |
96
-244
| -72% | -$4.96K | ﹤0.01% | 2237 |
|
|
2022
Q3 | $9K | Buy |
340
+244
| +254% | +$6.46K | ﹤0.01% | 1362 |
|
|
2022
Q2 | $2K | Hold |
96
| – | – | ﹤0.01% | 1928 |
|
|
2022
Q1 | $2K | Sell |
96
-98
| -51% | -$2.04K | ﹤0.01% | 1968 |
|
|
2021
Q4 | $4K | Buy |
194
+42
| +28% | +$866 | ﹤0.01% | 1566 |
|
|
2021
Q3 | $3K | Sell |
152
-162
| -52% | -$3.2K | ﹤0.01% | 1391 |
|
|
2021
Q2 | $7K | Buy |
314
+78
| +33% | +$1.74K | ﹤0.01% | 1177 |
|
|
2021
Q1 | $6K | Buy |
236
+59
| +33% | +$1.5K | ﹤0.01% | 1193 |
|
|
2020
Q4 | $5K | Buy |
177
+81
| +84% | +$2.29K | ﹤0.01% | 1171 |
|
|
2020
Q3 | $2K | Buy |
96
+46
| +92% | +$958 | ﹤0.01% | 1370 |
|
|
2020
Q2 | $1K | Hold |
50
| – | – | ﹤0.01% | 1529 |
|
|
2020
Q1 | $1K | Buy |
+50
| New | +$1K | ﹤0.01% | 1420 |
|